With more and more of us buying stuff online, it's no wonder that we are increasingly reaching out to fellow consumers for their seal of approval (or gripes) about products and services, and that's great news for reviews business Trustpilot (TRST). The platform now hosts more than 300 million consumer reviews of products and services across hundreds of thousands of websites, according to half y...

Shares in Rightmove (RMV) were little changed at 673p in morning trading after the online property portal rejected an initial £5.6 billion takeover offer from Australian property listing company REA Group (REA:ASX), controlled by Rupert Murdoch's News Corp. The Rightmove board said in a statement it had 'carefully considered the proposal, together with its financial advisers, and concluded it...

For investors in pest control and hygiene group Rentokil (RTO) this will be a day to forget after the firm released an unscheduled trading update warning profits would be lower than expected due to lower sales and higher costs. The shares were roiled, dropping 85p or almost 18% to a new 12-month low of 390p marking their lowest level since the pandemic. SALES WEAKER THAN ESTIMATED Today's annou...

Stocks in London made steady progress in early exchanges on Wednesday, although Rentokil slumped, ahead of key US inflation figures later. The data is released at 1330 BST. Data is expected to show the rate of annual US consumer price inflation faded to 2.6% in August, from 2.9% in July. The first US presidential debate between candidates Kamala Harris and Donald Trump took place late Tuesday....

London's FTSE 100 index fell on Tuesday, amid share price falls for some of its largest constituents, including AstraZeneca, BP and Shell. The FTSE 100 index fell 64.86 points, or 0.8%, at 8,205.98. The FTSE 250 ended flat at 20,656.14, and the AIM All-Share eased 2.87 points, or 0.4%, at 743.86.5. The Cboe UK 100 slid 0.6% to 821.91, the Cboe UK 250 rose 0.1% at 18,185.65, and the Cboe Small C...

Shares in pharmaceutical giant AstraZeneca (AZN), fell more than 5% to a one month low after the UK's largest quoted company released disappointing data from a late-stage clinical trial of its precision lung cancer drug Dato-DxD. The shares have been on a tear over the last six months, gaining around 20% before today's fall compared with a 7% gain in the FTSE 100 index, so some profit taking is...

Blue chips traded lower at midday on Tuesday, pegged back by falls in several index heavyweights, in a mixed day for stocks in London. The FTSE 100 index traded down 43.48 points, 0.5%, at 8,227.36. The FTSE 250 was up 32.47 points, 0.2%, at 20,683.35, and the AIM All-Share was down 0.69 of a point, 0.1%, at 746.04. The Cboe UK 100 was down 0.4% at 823.76, the Cboe UK 250 rose 0.4% at 18,228.80...

Shares in Centamin (CEY) jumped 24% to 149p after the Egyptian gold producer agreed terms on a cash and shares offer from global gold miner AngloGold Ashanti (ANG:JSE) pitched at 163p, representing a 36.7% premium on the prior closing price. AngloGold's cash and shares offer values Centamin at approximately £1.9 billion ($2.5 billion). Centamin shareholders will be entitled to receive the int...

Launching a new iPhone used to be a very big deal for Apple (AAPL:NASDAQ) and have customers queuing round the block. We'll have to wait until later this month (20 Sep) to see if those queues appear since it won't be available until then, but the event rather fizzled out. Investors were certainly left unimpressed and Apple stock has eased back a percentage point or two in pre-market data. AI-PO...

London's FTSE 100 fell in early trading on Tuesday, underperforming European peers, pegged back by a sharp fall in AstraZeneca shares. The FTSE 100 index traded down 27.30 points, 0.3%, at 8,243.54. The FTSE 250 was up 57.16 points, 0.3%, at 20,708.04, and the AIM All-Share was down 0.87 of a point, 0.1%, at 747.60. The Cboe UK 100 was down 0.2% at 824.77, the Cboe UK 250 rose 0.4% at 18,235.85...

European markets started the week on the front foot, with US inflation figures to be in focus this week, ahead of the Federal Reserve's rate call next Wednesday. The FTSE 100 index rose 89.37 points, or 1.1%, at 8,270.84. The FTSE 250 advanced 156.88 points, or 0.8%, at 20,650.88, and the AIM All-Share gained 2.73 points, or 0.4%, at 746.73. The Cboe UK 100 rose 1.2% to 826.66, the Cboe UK 250...

Shareholders in beer and cider producer C&C Group (CCR) celebrated a small win after the company confirmed its half-year profit forecast and continued its share buyback with a small but symbolic programme to buy €15 million (£12.7 million) of stock starting today. The shares rose 2% to 154p, outpacing the FTSE 250 mid-cap benchmark which was up around 0.6% by late morning. ON TARGET DESPITE...

London's FTSE 100 was higher at midday, although Burberry suffered, ahead of US inflation figures and the latest round of central bank interest rate calls. The FTSE 100 index traded up 49.96 points, or 0.6%, at 8,231.43. The FTSE 250 was 76.94 points higher, 0.4%, at 20,570.94, and the AIM All-Share was up 2.42 points, or 0.3%, at 746.42. The Cboe UK 100 was up 0.7% at 823.23, the Cboe UK 250 a...